Mileage Matters Episode 60

Drive Capital
Aug 20, 2018 · 1 min read

This week we question how to discover innovations that can stand the test of time in a world where technology is constantly advancing. We also look at the process in which biotech drug companies grow without having to spend valuable time on research and development. Lastly, an endorsement for the book Shoe Dog — highlighting Nike’s struggle to acquire the capital needed to keep up with demand.

Listen in below as we openly discuss the best opportunities of the week. We’ll see you next Friday.

Mileage Matters is recorded live at the start of every Drive Capital Partner meeting. We kick off our week with a discussion of the things that caught our attention over the past seven days. We’re going to begin sharing these musings in the form of a short podcast. Our goal is to give entrepreneurs a glimpse into how we think about the markets we cover (and more). We’d love to hear from you, and learn what’s catching your attention these days too. Let us know what you think on Twitter or drop us a line.

Welcome to a place where words matter. On Medium, smart voices and original ideas take center stage - with no ads in sight. Watch
Follow all the topics you care about, and we’ll deliver the best stories for you to your homepage and inbox. Explore
Get unlimited access to the best stories on Medium — and support writers while you’re at it. Just $5/month. Upgrade

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store